Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - crizotinibum - capsule rigide - crizotinibum 200 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 0.84 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - onkologikum - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - crizotinibum - capsule rigide - crizotinibum 250 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 1.05 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - onkologikum - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - levomenolum, matricariae extractum ethanolicum liquidum - liquido - levomenolum 0.35 mg, matricariae extractum ethanolicum liquidum 999.65 mg, der: 1:1.5-2.8 corresp. aetherolea 2.0-2.3 mg, auszugsmittel: ethanolum 96 per centum et ammoniae solutio concentrata et aqua purificata 51:1:48 ad solutionem pro 1 g corresp. ethanolum 422 mg/ml. - in caso di infiammazioni della pelle e della mucosa orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - idarubicini hydrochloridum - capsule rigide - idarubicini hydrochloridum 5 mg, cellulosum microcristallinum, glyceroli palmitostearas, gelatina, e 171, e 172 (rubrum), lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - farmaco - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - idarubicini hydrochloridum - capsule rigide - idarubicini hydrochloridum 10 mg, cellulosum microcristallinum, glyceroli palmitostearas, gelatina, e 171, e 172 (rubrum), lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - farmaco - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - pomalidomidum - capsule rigide - pomalidomidum 1 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.018 mg, kapselhülle: gelatina, e 171, e 132, e 172 (flavum), drucktinte: lacca, e 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - il trattamento del mieloma multiplo - synthetika